MedKoo Cat#: 527960 | Name: Lufuradom

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Lufuradom is a bioactive chemical.

Chemical Structure

Lufuradom
Lufuradom
CAS#85118-42-9

Theoretical Analysis

MedKoo Cat#: 527960

Name: Lufuradom

CAS#: 85118-42-9

Chemical Formula: C22H20FN3O2

Exact Mass: 377.1540

Molecular Weight: 377.42

Elemental Analysis: C, 70.01; H, 5.34; F, 5.03; N, 11.13; O, 8.48

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Lufuradom
IUPAC/Chemical Name
(+-)-N-((8-Fluoro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepin-2-yl)methyl)-3-furamide
InChi Key
QJSCDZOUCFWCKD-UHFFFAOYSA-N
InChi Code
InChI=1S/C22H20FN3O2/c1-26-18(13-25-22(27)16-9-10-28-14-16)12-24-21(15-5-3-2-4-6-15)19-8-7-17(23)11-20(19)26/h2-11,14,18H,12-13H2,1H3,(H,25,27)
SMILES Code
O=C(NCC1N(C)C2=CC(F)=CC=C2C(C3=CC=CC=C3)=NC1)C4=COC=C4
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 377.42 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Kawaguchi T, Tokushige K, Hyogo H, Aikata H, Nakajima T, Ono M, Kawanaka M, Sawada K, Imajo K, Honda K, Takahashi H, Mori K, Tanaka S, Seko Y, Nozaki Y, Kamada Y, Fujii H, Kawaguchi A, Takehara T, Yanase M, Sumida Y, Eguchi Y, Seike M, Yoneda M, Suzuki Y, Saibara T, Karino Y, Chayama K, Hashimoto E, George J, Torimura T. A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD. Sci Rep. 2018 Jul 11;8(1):10434. doi: 10.1038/s41598-018-28650-0. PubMed PMID: 29992975; PubMed Central PMCID: PMC6041283. 2: Kuo YT, Liou JM, El-Omar EM, Wu JY, Leow AHR, Goh KL, Das R, Lu H, Lin JT, Tu YK, Yamaoka Y, Wu MS; Asian Pacific Alliance on Helicobacter and Microbiota. Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017 Oct;2(10):707-715. doi: 10.1016/S2468-1253(17)30219-4. Epub 2017 Aug 7. Review. PubMed PMID: 28781119. 3: Morioka H, Itani O, Osaki Y, Higuchi S, Jike M, Kaneita Y, Kanda H, Nakagome S, Ohida T. The association between alcohol use and problematic internet use: A large-scale nationwide cross-sectional study of adolescents in Japan. J Epidemiol. 2017 Mar;27(3):107-111. doi: 10.1016/j.je.2016.10.004. Epub 2017 Jan 17. PubMed PMID: 28142042; PubMed Central PMCID: PMC5350616. 4: Komori Y, Iwashita Y, Ohta M, Kawano Y, Inomata M, Kitano S. Effects of different pressure levels of CO2 pneumoperitoneum on liver regeneration after liver resection in a rat model. Surg Endosc. 2014 Aug;28(8):2466-73. doi: 10.1007/s00464-014-3498-6. Epub 2014 Mar 12. PubMed PMID: 24619333. 5: Kusano T, Etoh T, Inomata M, Shiraishi N, Kitano S. CO(2) pneumoperitoneum increases secretory IgA levels in the gut compared with laparotomy in an experimental animal model. Surg Endosc. 2014 Jun;28(6):1879-85. doi: 10.1007/s00464-013-3408-3. Epub 2014 Jan 18. PubMed PMID: 24442682. 6: Koga H, Hagiwara S, Inomata M, Kono Y, Oyama Y, Kai S, Nishida T, Noguchi T. The new vitamin E derivative, ETS-GS, protects against cecal ligation and puncture-induced systemic inflammation in rats. Inflammation. 2012 Apr;35(2):545-53. doi: 10.1007/s10753-011-9344-2. PubMed PMID: 21603971. 7: Kume O, Takahashi N, Wakisaka O, Nagano-Torigoe Y, Teshima Y, Nakagawa M, Yufu K, Hara M, Saikawa T, Yoshimatsu H. Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats. Heart Rhythm. 2011 Feb;8(2):278-85. doi: 10.1016/j.hrthm.2010.10.029. Epub 2010 Oct 26. PubMed PMID: 21034856. 8: Hagiwara S, Iwasaka H, Hasegawa A, Asai N, Uchida T, Noguchi T. Dendritic cell activation in response to ischemia-reperfusion injury of the small intestine. Surg Today. 2010;40(2):137-45. doi: 10.1007/s00595-009-4033-6. Epub 2010 Jan 28. PubMed PMID: 20107953. 9: Hagiwara S, Iwasaka H, Shingu C, Matsumoto S, Uchida T, Noguchi T. High-dose antithrombin III prevents heat stroke by attenuating systemic inflammation in rats. Inflamm Res. 2010 Jul;59(7):511-8. doi: 10.1007/s00011-009-0155-y. Epub 2010 Jan 3. PubMed PMID: 20047080. 10: Hagiwara S, Iwasaka H, Shingu C, Matsumoto S, Uchida T, Noguchi T. Antithrombin III prevents cerulein-induced acute pancreatitis in rats. Pancreas. 2009 Oct;38(7):746-51. doi: 10.1097/MPA.0b013e3181aba9fa. PubMed PMID: 19546838. 11: Miyakawa H, Kira S, Okuda K, Takeshima N, Mori M, Noguchi T. Olprinone decreases elevated concentrations of cytokine-induced neutrophil chemoattractant-1 in septic rats. J Anesth. 2008;22(1):27-31. doi: 10.1007/s00540-007-0572-4. Epub 2008 Feb 27. PubMed PMID: 18306010. 12: Hagiwara S, Iwasaka H, Matsumoto S, Noguchi T. High dose antithrombin III inhibits HMGB1 and improves endotoxin-induced acute lung injury in rats. Intensive Care Med. 2008 Feb;34(2):361-7. Epub 2007 Oct 17. PubMed PMID: 17940748. 13: Hagiwara S, Iwasaka H, Matsumoto S, Noguchi T. Introduction of antisense oligonucleotides to heat shock protein 47 prevents pulmonary fibrosis in lipopolysaccharide-induced pneumopathy of the rat. Eur J Pharmacol. 2007 Jun 14;564(1-3):174-80. Epub 2007 Mar 12. Retraction in: Eur J Pharmacol. 2016 Dec 5;792:80. PubMed PMID: 17400207. 14: Hagiwara S, Iwasaka H, Matsumoto S, Noguchi T, Yoshioka H. Coexpression of HSP47 gene and type I and type III collagen genes in LPS-induced pulmonary fibrosis in rats. Lung. 2007 Jan-Feb;185(1):31-7. Epub 2007 Feb 15. Retraction in: Lung. 2015 Aug;193(4):617. PubMed PMID: 17310300. 15: Sawae Y, Niho Y, Okamura T, Gondo H, Kozuru M, Uike N, Muta K, Goto T, Suehiro Y, Kumakawa M, Nishimura J, Yufu Y, Ishikura H, Yamashita S, Hisano S, Morioka E, Nakajima H, Shibuya T, Yamasaki K, Harada N, Asayama R, Hayashi S, Akashi K, Suematsu E, Kawasaki C, et al. [Comparison between monotherapy with imipenem/cilastatin sodium (IPM/CS) and combinations of IPM/CS and other drugs for treating bacterial infections in patients with hematopoietic disorders]. Jpn J Antibiot. 1996 Dec;49(12):1049-61. Japanese. PubMed PMID: 9032592.